Acasti Pharma (NASDAQ: ACST) A Possible Merger or Strategic Plan in Course? Set for a Breakout with 350% Upside Potential
Shares of Acasti Pharma spiked to a 52 week high of $1.09 during the early Thursday trading sessions. 216 Million shares of Acasti Pharma was traded today compared to the average volume of 35 Million. Meanwhile, Acasti Pharma initiates a review process to evaluate strategic alternatives to boost shareholder value. In a statement, the Laval, […]
Read More